As of 2026-06-26, Allogene Therapeutics, Inc. Common Stock (ALLO) has a 3-month relative strength percentile of 24 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 61. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 6.7%, relative volume 3.09×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
ALLO ranks at the 35th percentile over 1 month, 24th percentile over 3 months, 90th percentile over 6 months, 84th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
ALLO is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data.
Sector RS percentile is not available for Healthcare at this snapshot. Leading sector status (threshold: Healthcare RS ≥ 70th percentile) cannot be determined until the next sector RS pipeline run.
ALLO currently shows a 20-day average daily range (ADR%) of 6.7%, a 90-day beta versus the S&P 500 of 2.17. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
TickerStance computes ALLO's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what ALLO has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.
ALLO most recently filed a 10-Q covering FY26 Q1 with the SEC on 2026-05-13. TickerStance sources earnings data from SEC EDGAR XBRL submissions and updates the fundamentals panel daily. The Pro dossier shows eight quarters of EPS and revenue trend, operating margin history, and a composite earnings-quality rank.
§ Seasonality
10y · since 2022
Best monthFebon averageavg +20.29% · 75% win · n 4
Worst monthMaron averageavg -17.13% · 0% win · n 4
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
+12.8%
+20.3%
-17.1%
40%
20%
+7.1%
+12.2%
-8.7%
-5.9%
-6.1%
-1.5%
-5.0%
ALLO monthly seasonality strip
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
1
ALLO Jan
avg: 12.80%
median: 16.20%
win: 75%
σ: 21.38%
n: 4
2022-04-12 → 2026-05-29
ALLO Feb
avg: 20.29%
median: 23.91%
win: 75%
σ: 31.13%
n: 4
2022-04-12 → 2026-05-29
ALLO Mar
avg: -17.13%
median: -17.22%
win: 0%
σ: 7.76%
n: 4
2022-04-12 → 2026-05-29